Renovaro Inc. - Common Stock (NQ: RENB )
1.770
+0.330
(+22.92%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 6, 2024
Add to My Watchlist
All News about Renovaro Inc. - Common Stock
Study Shows Ongoing Benefits Once Immunotherapy Stops
January 02, 2024
Researchers Harnessing Immune System to Fight Cancer More Effectively
December 07, 2023
Study Says Patients on Gene Therapy Need Long-Term Monitoring
November 27, 2023
Unlocking AI investment opportunities in healthcare
November 16, 2023
Via MarketBeat
Exposures
Artificial Intelligence
How Immunotherapy Is Cementing a Role in Cancer Treatment
November 13, 2023
Alarming Data Highlights Gaps in Treating People with Chronic HBV
November 01, 2023
12 Health Care Stocks Moving In Friday's Intraday Session
October 20, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|